The significance of expression pattern of prostaglandin transporter in clincial prognosis and pathophysiology in human gastric adenocarcinoma

The significance of expression pattern of prostaglandin transporter in clincial prognosis and pathophysiology in human gastric adenocarcinoma - The significance of expression pattern of prostaglandin transporter in clincial prognosis and pathophysiology in human gastric adenocarcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016237

Enrollment

110

Registered

2015-01-17

Start date

2014-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric adenocarcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) The subjects who agree to participate in the study by written informed consent. 2) The subjects who are diagnosed as gastric adenocarcinoma and undergo an operation, ecdoscopic resection and gastrectomy at our hospital from 1999 to 2003.

Exclusion criteria

Exclusion criteria: The subjects who are judged to be inappropriate for this study by doctors conducting the study.

Design outcomes

Primary

Measure	Time frame
Prognosis in gastric adenocarcinoma	—

Secondary

Measure	Time frame
Angiogenesis Cell proliferation	—

Countries

Japan

Contacts

Public ContactTetsuya Tanigawa

Osaka City University Graduate School of Medicine Gastroenterology

ttanigawa@med.osaka-cu.ac.jp06-6645-3811

Outcome results